Denali Therapeutics Inc. (DNLI)

NASDAQ: DNLI · Real-Time Price · USD

19.96

-0.15 (-0.75%)

At close: Dec 5, 2025, 4:00 PM EST

19.70

-0.26 (-1.30%)

After-hours: Dec 5, 2025, 7:26 PM EST

Denali Therapeutics Market Cap

Denali Therapeutics has a market cap or net worth of $2.93 billion as of December 5, 2025. Its market cap has decreased by -15.88% in one year.

Market Cap

2.93B

Enterprise Value

2.10B

1-Year Change

-15.88%

Ranking

#1733

Market Cap Chart

Since December 8, 2017, Denali Therapeutics's market cap has increased from $1.89B to $2.93B, an increase of 55.12%. That is a compound annual growth rate of 5.65%.

Market Cap History

Date	Market Cap	% Change
Dec 4, 2025	2.95B	0.55%
Dec 31, 2024	2.93B	-1.10%
Dec 29, 2023	2.97B	-21.48%
Dec 30, 2022	3.78B	-30.66%
Dec 31, 2021	5.45B	-45.77%
Dec 31, 2020	10.04B	500.43%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	908.36B
Johnson & Johnson	487.83B
AbbVie	404.22B
UnitedHealth Group	302.09B
AstraZeneca	279.81B
Novartis AG	255.73B
Merck & Co.	250.41B
Abbott Laboratories	218.05B

Market Cap Rankings